Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Lapam Capital: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Lapam Capital
Lapam Capital
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Lapam Capital.
JL
Jian Li
N/A
ZY
Zhihua Yu
N/A
Leadership Team
Key people at Lapam Capital.
JL
Jian Li
N/A
ZY
Zhihua Yu
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Dec 19, 2025
Ningkang Ruizhu
$20.0M Series A
Lapam Capital
Riverhead Capital
Dec 16, 2025
Allink Biotherapeutics
$47.0M Series A Extension
郭学婧
, Tan Hong
5Y Capital
Nov 25, 2025
Phrontline Biopharma
$60.0M Pre-Series A
王及
Decheng Capital
,
Med-Fine Capital
, Samsung
,
Sino Biopharmaceutical
Oct 16, 2025
BridGene Biosciences
$28.0M Series B
Yuexing Su
Grains Valley Venture Capital
,
GTJA Investment Group
,
Proxima Ventures
Sep 30, 2025
Full-Life Technologies
$77.0M Life Technologies - Debt / Series C
Wei Shen
Chengwei Capital
,
Plaisance Capital Management
,
Prosperity7 Ventures
,
Sequoia Capital
,
Summer Capital
,
TruMed Investment
Sep 8, 2025
Rapafusyn Pharmaceuticals
$44.0M Series A
—
Karen Liu
, Jian Li
, Haolin Sung
, Wen Chen
Sep 1, 2025
Epigenic Therapeutics
$60.0M Series B
Zhihua Yu
OrbiMed
,
IFSC
,
Qiming Venture Partners
May 1, 2025
EnChannel Medical
$83.9M Series B
DragonBall Capital
,
Lilly Asia Ventures
—
Jul 1, 2024
ReviR Therapeutics
$30.0M Series A
Lapam Capital
5Y Capital
Jul 1, 2024
LTZ Therapeutics
$20.0M Series A
Lapam Capital
Qiming Venture Partners
Jun 24, 2024
Rapafusyn Pharmaceuticals
$28.0M Series A
Karen Liu
,
Proxima Ventures
Zhihua Yu
May 25, 2023
DeepKinase
$14.2M Series A Extension
Zhihua Yu
Feifan Venture Capital
,
Fengrui Capital
,
Zhongguancun Development Group
Oct 3, 2022
NeuShen Therapeutics
$20.0M Pre-Series A
Zhihua Yu
—
Jul 28, 2022
BridGene Biosciences
$38.5M Series B
Dyee Capital
,
Junson Capital
,
Lapam Capital
—
Jun 13, 2022
First Technology
$100.0M Series C
—
Cherami Investment Group
,
Jintan Capital
Oct 12, 2021
Chance Pharmaceuticals
$30.0M Series C
Zhihua Yu
Guozhong Capital
,
HEDA BioVenture
Aug 18, 2021
Ranok Therapeutics
$40.0M Series B
Zhihua Yu
, Hong Wen
Wu Capital
,
Zhongguancun Kaiyuan Capital
Sep 29, 2020
Hugo Biotech
$32.0M Series A
Lapam Capital
, Lee Kai-Fu
—
Nov 28, 2019
Clover Biopharmaceuticals
$43.3M Series B
Tim Xiao
, Guangyu Xu
—
Dec 28, 2017
Asieris Pharmaceuticals
$15.0M Series B
Zhihua Yu
—
Nov 15, 2017
Cygnus Biosciences
$19.6M Other Equity
Lu Zhang
, Long Yibin
Jingming BAO
,
Jinggong Hongyuan
, Zhihua Yu
, Star Ventures
May 1, 2017
CANbridge Pharmaceuticals
$25.0M Series B
Lapam Capital
Qiming Venture Partners
,
Biossom Investment Management
,
Haoyue Capital
,
WuXi AppTec
,
Yanyuan Capital
,
YuanMing Capital
Jan 1, 2017
Connect Biopharmaceuticals
$20.0M Series A
Qiming Venture Partners
Co-win Ventures
,
Northern Light Venture Capital
Jan 1, 2014
Insgeek
$16.5M Series B
—
Legend Holdings